1. Home
  2. SIDU vs CYCN Comparison

SIDU vs CYCN Comparison

Compare SIDU & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sidus Space Inc.

SIDU

Sidus Space Inc.

SELL

Current Price

$1.90

Market Cap

105.1M

ML Signal

SELL

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

HOLD

Current Price

$1.35

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIDU
CYCN
Founded
2012
2018
Country
United States
United States
Employees
104
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.1M
7.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SIDU
CYCN
Price
$1.90
$1.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
41.0M
43.1K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,623,538.00
$2,855,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1371.65
52 Week Low
$0.63
$1.28
52 Week High
$6.75
$6.25

Technical Indicators

Market Signals
Indicator
SIDU
CYCN
Relative Strength Index (RSI) 60.65 32.47
Support Level $1.35 $1.43
Resistance Level $2.59 $1.51
Average True Range (ATR) 0.36 0.11
MACD 0.13 -0.01
Stochastic Oscillator 42.25 0.69

Price Performance

Historical Comparison
SIDU
CYCN

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: